Journal of Virology, June 2003, p. 6811-6822, Vol. 77, No. 12
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.12.6811-6822.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Turnover of env Variable Region 1 and 2 Genotypes in Subjects with Late-Stage Human Immunodeficiency Virus Type 1 Infection
Kathryn M. Kitrinos,1,2 Noah G. Hoffman,1,3 Julie A. E. Nelson,1,
and Ronald Swanstrom1,4*
UNC Center for AIDS Research,1
Curriculum of Genetics and Molecular Biology,2
Department of Microbiology and Immunology,3
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-72954
Received 10 January 2003/
Accepted 27 March 2003
The env gene of human immunodeficiency virus type 1 (HIV-1) includes some of the most genetically diverse regions of the viral genome, which are called variable regions 1 through 5 (V1 through V5). We have developed a heteroduplex tracking assay to detect changes in variable regions 1 and 2 of env (V1/V2-HTA). Using sequences from two molecular clones as probes, we have studied the nature of longitudinal virus population changes in a cohort of HIV-1-infected subjects. Viral sequences present in 21 subjects with late-stage HIV-1 infection were initially screened for stability of the virus population by V1/V2-HTA. The virus populations at entry comprised an average of five coexisting V1/V2 genotypic variants (as identified by HTA). Eight of the 21 subjects were examined in detail because of the dynamic behavior of their env variants over an approximately 9-month period. In each of these cases we detected a single discrete transition of V1/V2 genotypes based on monthly sampling. The major V1/V2 genotypes (those present at >10% abundance) from the eight subjects were cloned and sequenced to define the nature of V1/V2 variability associated with a discrete transition. Based on a comparison of V1/V2 genotypic variants present at entry with the newly emerged variants we categorized the newly emerged variants into two groups: variants without length differences and variants with length differences. Variants without length differences had fewer nucleotide substitutions, with the changes biased to either V1 or V2, suggestive of recent evolutionary events. Variants with length differences included ones with larger numbers of changes that were distributed, suggestive of recall of older genotypes. Most length differences were located in domains where the codon motif AVT (V = A, G, C) had become enriched and fixed. Finally, recombination events were detected in two subjects, one of which resulted in the reassortment of V1 and V2 regions. We suggest that turnover in V1/V2 populations was largely driven by selection on either V1 or V2 and that escape was accomplished either through changes focused in the region under selection or by the appearance of a highly divergent variant.
* Corresponding author. Mailing address: University of North Carolina at Chapel Hill, 22-062 Lineberger Cancer Center, CB 7295, Chapel Hill, NC 27599-7295. Phone: (919) 966-5710. Fax: (919) 966-8212. E-mail: risunc{at}med.unc.edu.
Present address: Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH 45267-0524.
Journal of Virology, June 2003, p. 6811-6822, Vol. 77, No. 12
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.12.6811-6822.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Duggal, N. K., Goo, L., King, S. R., Telesnitsky, A.
(2007). Effects of Identity Minimization on Moloney Murine Leukemia Virus Template Recognition and Frequent Tertiary Template-Directed Insertions during Nonhomologous Recombination. J. Virol.
81: 12156-12168
[Abstract]
[Full Text]
-
Voronin, Y., Chohan, B., Emerman, M., Overbaugh, J.
(2007). Primary Isolates of Human Immunodeficiency Virus Type 1 Are Usually Dominated by the Major Variants Found in Blood. J. Virol.
81: 10232-10241
[Abstract]
[Full Text]
-
Harrington, P. R., Nelson, J. A. E., Kitrinos, K. M., Swanstrom, R.
(2007). Independent Evolution of Human Immunodeficiency Virus Type 1 env V1/V2 and V4/V5 Hypervariable Regions during Chronic Infection. J. Virol.
81: 5413-5417
[Abstract]
[Full Text]
-
Kwiek, J. J., Alker, A. P., Wenink, E. C., Chaponda, M., Kalilani, L. V., Meshnick, S. R.
(2007). Estimating True Antimalarial Efficacy by Heteroduplex Tracking Assay in Patients with Complex Plasmodium falciparum Infections. Antimicrob. Agents Chemother.
51: 521-527
[Abstract]
[Full Text]
-
Riddle, T. M., Shire, N. J., Sherman, M. S., Franco, K. F., Sheppard, H. W., Nelson, J. A. E.
(2006). Sequential Turnover of Human Immunodeficiency Virus Type 1 env throughout the Course of Infection. J. Virol.
80: 10591-10599
[Abstract]
[Full Text]
-
Kitrinos, K. M., Nelson, J. A. E., Resch, W., Swanstrom, R.
(2005). Effect of a Protease Inhibitor-Induced Genetic Bottleneck on Human Immunodeficiency Virus Type 1 env Gene Populations. J. Virol.
79: 10627-10637
[Abstract]
[Full Text]
-
Ritola, K., Robertson, K., Fiscus, S. A., Hall, C., Swanstrom, R.
(2005). Increased Human Immunodeficiency Virus Type 1 (HIV-1) env Compartmentalization in the Presence of HIV-1-Associated Dementia. J. Virol.
79: 10830-10834
[Abstract]
[Full Text]
-
Harrington, P. R., Haas, D. W., Ritola, K., Swanstrom, R.
(2005). Compartmentalized Human Immunodeficiency Virus Type 1 Present in Cerebrospinal Fluid Is Produced by Short-Lived Cells. J. Virol.
79: 7959-7966
[Abstract]
[Full Text]
-
NGRENNGARMLERT, W., KWIEK, J. J., KAMWENDO, D. D., RITOLA, K., SWANSTROM, R., WONGSRICHANALAI, C., MILLER, R. S., ITTARAT, W., MESHNICK, S. R.
(2005). MEASURING ALLELIC HETEROGENEITY IN PLASMODIUM FALCIPARUM BY A HETERODUPLEX TRACKING ASSAY. Am J Trop Med Hyg
72: 694-701
[Abstract]
[Full Text]
-
Zerhouni, B., Nelson, J. A. E., Saha, K.
(2004). CXCR4-Dependent Infection of CD8+, but Not CD4+, Lymphocytes by a Primary Human Immunodeficiency Virus Type 1 Isolate. J. Virol.
78: 12288-12296
[Abstract]
[Full Text]
-
Ritola, K., Pilcher, C. D., Fiscus, S. A., Hoffman, N. G., Nelson, J. A. E., Kitrinos, K. M., Hicks, C. B., Eron, J. J. Jr., Swanstrom, R.
(2004). Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1. J. Virol.
78: 11208-11218
[Abstract]
[Full Text]
-
Mackay, G. A., Liu, Z., Singh, D. K., Smith, M. S., Mukherjee, S., Sheffer, D., Jia, F., Adany, I., Sun, K. H., Dhillon, S., Zhuge, W., Narayan, O.
(2004). Protection Against Late-Onset AIDS in Macaques Prophylactically Immunized with a Live Simian HIV Vaccine Was Dependent on Persistence of the Vaccine Virus. J. Immunol.
173: 4100-4107
[Abstract]
[Full Text]
-
Fulcher, J. A., Hwangbo, Y., Zioni, R., Nickle, D., Lin, X., Heath, L., Mullins, J. I., Corey, L., Zhu, T.
(2004). Compartmentalization of Human Immunodeficiency Virus Type 1 between Blood Monocytes and CD4+ T Cells during Infection. J. Virol.
78: 7883-7893
[Abstract]
[Full Text]
-
Kapoor, A., Jones, M., Shafer, R. W., Rhee, S.-Y., Kazanjian, P., Delwart, E. L.
(2004). Sequencing-Based Detection of Low-Frequency Human Immunodeficiency Virus Type 1 Drug-Resistant Mutants by an RNA/DNA Heteroduplex Generator-Tracking Assay. J. Virol.
78: 7112-7123
[Abstract]
[Full Text]
-
Rybarczyk, B. J., Montefiori, D., Johnson, P. R., West, A., Johnston, R. E., Swanstrom, R.
(2004). Correlation between env V1/V2 Region Diversification and Neutralizing Antibodies during Primary Infection by Simian Immunodeficiency Virus sm in Rhesus Macaques. J. Virol.
78: 3561-3571
[Abstract]
[Full Text]
-
Kuhmann, S. E., Pugach, P., Kunstman, K. J., Taylor, J., Stanfield, R. L., Snyder, A., Strizki, J. M., Riley, J., Baroudy, B. M., Wilson, I. A., Korber, B. T., Wolinsky, S. M., Moore, J. P.
(2004). Genetic and Phenotypic Analyses of Human Immunodeficiency Virus Type 1 Escape from a Small-Molecule CCR5 Inhibitor. J. Virol.
78: 2790-2807
[Abstract]
[Full Text]
-
Zerhouni, B., Nelson, J. A. E., Saha, K.
(2004). Isolation of CD4-Independent Primary Human Immunodeficiency Virus Type 1 Isolates That Are Syncytium Inducing and Acutely Cytopathic for CD8+ Lymphocytes. J. Virol.
78: 1243-1255
[Abstract]
[Full Text]
-
Tsui, R., Herring, B. L., Barbour, J. D., Grant, R. M., Bacchetti, P., Kral, A., Edlin, B. R., Delwart, E. L.
(2004). Human Immunodeficiency Virus Type 1 Superinfection Was Not Detected following 215 Years of Injection Drug User Exposure. J. Virol.
78: 94-103
[Abstract]
[Full Text]
-
Nabatov, A. A., Pollakis, G., Linnemann, T., Kliphius, A., Chalaby, M. I. M., Paxton, W. A.
(2004). Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies. J. Virol.
78: 524-530
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.